Skip to content
Dr. Grey AI

Condition

Atherosclerosis

Atherosclerosis is a slow buildup of fatty plaque in artery walls, driven by cholesterol-carrying particles and inflammation, which narrows and stiffens the vessels. Berberine has the most research behind it, and small studies found lower C-reactive protein, a marker of inflammation; apolipoprotein A went up with niacin, and HDL cholesterol improved with L-carnitine. Still, the evidence is mostly limited, built on small trials, and naringenin's promise came largely from animal work.

Sources: PMID 22085343; PMID 19618992

Supplements studied
14
Graded outcomes
14
Trials
7
People studied
4,749

Evidence by supplement

  • Strong
  • Moderate
  • Limited
  • Very limited

14 supplements

L-Carnitine: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
High-density lipoprotein (HDL)

Small Improvement

Improves (the measure goes up)Small effect12 studies18 people
Total cholesterolImproves (the measure goes down)6 studies18 people
TriglyceridesImproves (the measure goes down)4 studies18 people
Neutrophil CountImproves (the measure goes up)1 study18 people

Studies that measured neutrophil count

Serum PlateletsImproves (the measure goes up)1 study18 people
Low-density lipoprotein (LDL)Improves (the measure goes down)18 people
Lymphocyte CountImproves (the measure goes up)18 people
Monocyte CountImproves (the measure goes up)18 people
TMAOImproves (the measure goes up)18 people
White Blood Cell CountImproves (the measure goes up)18 people

Naringenin: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Atherosclerosis Risk

A review of literature (PMID 25483717) summarizes consistent preclinical evidence that naringenin reduces LDL and triglycerides, increases HDL, suppresses macrophage inflammation, and inhibits foam cell formation. In mice, naringin reduced atherosclerotic plaque by 41% over 18 weeks (PMID 21684135). One human RCT showed reduced arterial stiffness (PMID 26016866), supporting vascular benefit.

Improves (the measure goes down)Moderate effect5 studies48 people

Studies that measured atherosclerosis risk

and 2 more on the Naringenin page

Phosphorus

  • Vascular Calcification: improves
Phosphorus: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Vascular Calcification

Mechanistic and observational studies demonstrate that excess phosphorus promotes pathological vascular calcification by inducing osteogenic differentiation of vascular smooth muscle cells. Clinical studies in CKD patients show phosphate burden accelerates arterial calcification and vascular stiffness.

Improves (the measure goes up)Moderate effect4 studies

Studies that measured vascular calcification

and 1 more on the Phosphorus page

Niacin (Vitamin B3)

  • Apolipoprotein A: improves
  • Apolipoprotein B: improves
  • Low-density lipoprotein (LDL): improves
Niacin (Vitamin B3): outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Apolipoprotein A

Small Increase

Improves (the measure goes up)Small effect1 study3,196 people

Studies that measured apolipoprotein a

Apolipoprotein BImproves (the measure goes down)3 studies3,196 people
Low-density lipoprotein (LDL)Improves (the measure goes down)2 studies3,196 people

Studies that measured low-density lipoprotein (ldl)

High-density lipoprotein (HDL)Improves (the measure goes up)1 study3,196 people

Studies that measured high-density lipoprotein (hdl)

Heart Attack RiskChanges; see studies3,196 people
Stroke RiskChanges; see studies3,196 people
TriglyceridesImproves (the measure goes down)3,196 people

Ginkgo Biloba

  • Microcirculation: improves
  • Oxidative Stress Biomarkers: improves
Ginkgo Biloba: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Microcirculation

Small Improvement

Improves (the measure goes up)Small effect1 study32 people
Oxidative Stress BiomarkersImproves (the measure goes down)32 people

Berberine

  • C-Reactive Protein (CRP): improves
  • Total cholesterol: improves
  • High-density lipoprotein (HDL): improves
Berberine: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
C-Reactive Protein (CRP)

Small Decrease

Improves (the measure goes down)Small effect120 people
Total cholesterolImproves (the measure goes down)3 studies689 people
High-density lipoprotein (HDL)Improves (the measure goes up)2 studies589 people
TriglyceridesImproves (the measure goes down)1 study689 people
Interleukin 6Improves (the measure goes down)240 people
Low-density lipoprotein (LDL)Improves (the measure goes down)689 people
TNF-AlphaImproves (the measure goes down)240 people

Policosanol

  • High-density lipoprotein (HDL): improves
  • Low-density lipoprotein (LDL): improves
  • Total cholesterol: improves
Policosanol: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
High-density lipoprotein (HDL)

Small Improvement

Improves (the measure goes up)Small effect179 people
Low-density lipoprotein (LDL)Improves (the measure goes down)10 studies179 people
Total cholesterolImproves (the measure goes down)3 studies179 people
TriglyceridesImproves (the measure goes down)179 people

Cyanidin

  • Endothelial Function: improves
Cyanidin: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Endothelial Function

In apolipoprotein E-deficient mice, C3G supplementation protected against hypercholesterolemia-mediated endothelial dysfunction, attenuated atherosclerosis, and promoted endothelial repair in diabetic models. In vitro, C3G attenuated angiotensin II-induced oxidative stress in vascular endothelial cells and modulated miR-204-5p/SIRT1-mediated inflammation and apoptosis. No human cardiovascular trials with isolated C3G.

Improves (the measure goes up)Moderate effect6 studies

Chinese Hawthorn

  • Atherosclerosis Progression: changes; see studies
Chinese Hawthorn: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Atherosclerosis Progression

Network pharmacology and animal pharmacology studies on the Danshen-Shanzha herb pair suggest protective effects against atherosclerosis. A 2026 study demonstrated synergistic promotion of fatty acid oxidation via PPARα, Plin-5, and Plin-2 activation in metabolic liver disease models.

Changes; see studiesSmall effect3 studies

Danshen

  • Atherosclerosis Progression: changes; see studies
Danshen: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Atherosclerosis Progression

In preclinical models, danshen compounds reduce oxidized LDL and inhibit smooth muscle cell hyperplasia after vascular injury (PMID:11367667). Magnesium lithospermate B protects human aortic endothelial cells from free radical damage in vitro (PMID:15250206). Human translation of these anti-atherogenic effects has not been established.

Changes; see studiesSmall effect2 studies

Studies that measured atherosclerosis progression

Flavanols

  • LDL Oxidation: improves
Flavanols: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
LDL Oxidation

In vitro studies show flavan-3-ols and procyanidins protect liposomes against lipid oxidation and bilayer disruption. Cocoa procyanidins protect LDL from oxidation regardless of polymer chain length when monomer units are controlled, suggesting monomeric flavanols are the active species.

Improves (the measure goes down)Moderate effect2 studies

Hederagenin

  • Atherosclerosis Progression: improves
Hederagenin: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Atherosclerosis Progression

In a Wistar rat atherosclerosis model (high-lipid diet + vitamin D3), hederagenin improved blood rheology and endothelial function, corrected iNOS/eNOS imbalance, and inhibited IKKβ/NF-κB signaling with results comparable to atorvastatin at statistical significance (P < 0.01).

Improves (the measure goes up)Moderate effect1 study

Studies that measured atherosclerosis progression

Vitamin C

  • Adiponectin
  • Triglycerides: improves
  • Blood glucose: improves
Vitamin C: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Adiponectin

No effect

NoneNo effect8 people
TriglyceridesImproves (the measure goes down)5 studies8 people
Blood glucoseImproves (the measure goes down)3 studies8 people
InflammationImproves (the measure goes down)2 studies8 people
Total cholesterolImproves (the measure goes down)2 studies8 people
C-Reactive Protein (CRP)Improves (the measure goes down)1 study8 people
High-density lipoprotein (HDL)Improves (the measure goes up)8 people
InsulinChanges; see studies8 people
LDL OxidationImproves (the measure goes down)8 people
Low-density lipoprotein (LDL)Improves (the measure goes down)8 people

Nicotinamide Mononucleotide

  • Endogenous Advanced Glycation End Products
  • Pulse Wave Velocity: improves
Nicotinamide Mononucleotide: outcomes studied for Atherosclerosis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Endogenous Advanced Glycation End Products

No effect

NoneNo effect36 people
Pulse Wave VelocityImproves (the measure goes down)1 study36 people

Key findings

  • High-density lipoprotein (HDL)L-CarnitineImproves (the measure goes up)
  • Atherosclerosis RiskNaringeninImproves (the measure goes down)
  • Vascular CalcificationPhosphorusImproves (the measure goes up)

The Atherosclerosis protocol

2 primary supplements · 4 supporting supplements

See the full protocol

Shop the evidence-backed picks

Support alongside medical care. These supplements are not a treatment for Atherosclerosis. If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.

Fullscript collectionHeart and circulation: evidence-graded picksOpen on Fullscript

We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure

Studies cited

2 studies from PubMed

  1. Effect of nuts on lipid profile and inflammatory biomarkers in atherosclerotic cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials.Eur J Nutr · PMID 38967674
  2. The antiatherosclerotic effect of Allium sativumAtherosclerosis · PMID 10381297